Date | Insider | Price | Amount |
---|---|---|---|
9-13-2022 Insider Buy |
Lindsay A. Rosenwald, M.D. Director |
$0.62 CAGR » |
$5,607.47 9,094 shares |
9-13-2022 Insider Buy |
Manuel Litchman, M.D. Director |
$0.63 CAGR » |
$6,277.00 10,000 shares |
10-27-2021 Insider Buy |
Manuel Litchman, M.D. President and CEO |
$2.24 CAGR » |
$145,600.00 65,000 shares |
3-5-2021 Insider Buy |
Manuel Litchman, M.D. President and CEO |
$3.12 CAGR » |
$516,553.44 165,562 shares |
12-14-2020 Insider Buy |
Lindsay A. Rosenwald, M.D. Director |
$2.66 CAGR » |
$266,000.00 100,000 shares |
5-21-2020 Insider Buy |
Manuel Litchman, M.D. President and CEO |
$2.96 CAGR » |
$532,800.00 180,000 shares |
11-23-2018 Insider Buy |
Neil Herskowitz Director |
$3.96 CAGR » |
$3,960.00 1,000 shares |
Also See: Institutional Holders of MBIO
Also See: SEC filings
Growth of $10,000.00 Without Dividends Reinvested |
||
Start date: | 09/14/2022 | |
End date: | 04/22/2024 | |
Start price/share: | $8.82 | |
End price/share: | $0.34 | |
Dividends collected/share: | $0.00 | |
Total return: | -96.15% | |
Average Annual Total Return: | -86.84% | |
Starting investment: | $10,000.00 | |
Ending investment: | $385.46 | |
Years: | 1.61 |
MBIO Insider Buying
This Holdings Channel page has presented insider buying activity, covering Directors, officers (such as CEO, CFO, COO, etc.), and >10% owners (who are required to file form 4's with the SEC). Important institutional owners may not fall under these categories, but instead file their holdings quarterly on the latest form 13F filings. While recent MBIO insider buying activity is included, there may also be stock sales over this same period (Also See: SEC filings for sales and other details).
Also See: Funds Holding MBIO
Free MBIO Email Alerts: Get Dividend Alerts Get SEC Filing Alerts |
Other companies seeing insider buying close in time to when the MBIO Insider Buying occurred are:
IGTA Insider Buying |